← Back to all trials
Not Yet Recruiting
NCT05650021
Rectal Spacer for Prostate Cancer Radiation Image Guidance
Conditions: Prostate Cancer
Sex: Male
Phase: NA
Enrollment: 30
Sponsor: Milton S. Hershey Medical Center
Summary
The purpose of the study is to determine if a radiopaque hydrogel rectal spacer, SpaceOAR Vue®, can be used in place of fiducial markers when aligning patients for radiotherapy.
The investigator hypothesizes that the alignment of the patient based on the rectal spacer will be similar to the alignment of the patient with fiducial markers.
Eligibility Criteria
Inclusion Criteria:Untreated cT1 - cT3 prostate cancerExclusion Criteria:Extracapsular extensionPrior prostate surgeryPrior prostate radiotherapy
Source: ClinicalTrials.gov (NCT05650021). StuddyBuddy aggregates publicly available trial information.
